Quark Venture

Quark Venture operates as a specialized venture capital investment firm, dedicated to providing equity financing for innovative biotechnology and health sciences companies. Headquartered in Vancouver, Canada, the firm focuses its investments on entities developing breakthrough technology platforms and projects within the life sciences sector, aiming to foster advancements in global healthcare.

The firm was established in 2015, with Karimah Es Sabar serving as its founding Chief Executive Officer and General Partner. The genesis of Quark Venture reflects a clear recognition of the essential role specialized capital plays in advancing early-stage scientific discoveries and supporting their translation into viable commercial applications within the dynamic health sciences landscape.

Quark Venture's primary clientele comprises biotechnology and health sciences companies requiring strategic financial backing to propel their research and development initiatives. Its overarching vision is to catalyze innovation that contributes meaningfully to medical progress, supporting the development of novel therapies and technologies that address significant health challenges and shape the future of medicine.